Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 171 | 70 | 3 |
Full Text Views | 6 | 0 | 0 |
PDF Downloads | 3 | 0 | 0 |
The incidence of viremia following vaccination with the 17D strain of yellow fever virus did not differ appreciably in a group of human subjects possessing prevaccination Japanese encephalitis neutralizing antibodies as a result of previous inapparent natural infection from the incidence of viremia in control groups possessing no prevaccination Group B arbor virus antibodies. There may have been a slight diminution in the level of circulating virus among the subjects with prevaccination JE neutralizing antibodies as compared with the level in the control groups; however, the number of uncontrolled factors which may have influenced these measurements precludes a firm conclusion on this matter.
Present address: Merck Institute for Research, West Point, Pennsylvania.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 171 | 70 | 3 |
Full Text Views | 6 | 0 | 0 |
PDF Downloads | 3 | 0 | 0 |